IXC Charting Thread, page-299

If there's a couple of mil set aside, that's good news.

But I'm still with @qwert0 here.... there shouldn't be any need for toxicity or dosage, we're already feeding this to humans, so we've passed that point. As a result, my assumption is that a second indication would be aimed at humans from the start.

However... there's certainly a lot of effort and some lead time between putting it forward to being able to get it started, including designing the end to end, sites, etc etc.

So if that could be achieved, and with a sensible timeline so that they wouldn't need additional funding for that indication until at least a month after read out, then I'm all ears